Drug Profile
Lonicera japonica
Alternative Names: Flos Lonicerae Japonicae - GC Pharma; GC-6101A; Japanese honeysuckle - GC Pharma; Lonicera japonica THUNB - GC Pharma; Lonicerae flos - GC PharmaLatest Information Update: 07 Feb 2018
Price :
$50
*
At a glance
- Originator Green Cross
- Developer GC Biopharma
- Class Kampo medicine; Traditional Chinese medicine
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Gastritis
Most Recent Events
- 29 Jul 2016 Lonicera japonica is still in phase II trials for Gastritis in South Korea (PO) (NCT02353039)
- 01 Sep 2014 Phase-II clinical trials in Gastritis in South Korea (PO)
- 23 Aug 2013 Preclinical trials in Gastritis in South Korea (PO)